2018
DOI: 10.1016/j.spinee.2017.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Role of Cerebrolysin in cervical spondylotic myelopathy patients: a prospective randomized study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 18 publications
0
10
0
Order By: Relevance
“…Nouri et al 182 (2020) in a retrospective analysis of 725 patients undergoing surgery for DCM or degenerative cervical radiculopathy, demonstrated macrocytic anemia was more common in DCM, and its presence associated with poorer pre-operative neurological status . Further, Allam et al 183 (2017) (61) conducted a randomized controlled study (N = 192), in patients declining surgery for DCM of Cerebrolysin, a mixture of amino-acids and peptides given via intramuscular injection, demonstrating neurological benefit for the treatment arm.…”
Section: Introductionmentioning
confidence: 99%
“…Nouri et al 182 (2020) in a retrospective analysis of 725 patients undergoing surgery for DCM or degenerative cervical radiculopathy, demonstrated macrocytic anemia was more common in DCM, and its presence associated with poorer pre-operative neurological status . Further, Allam et al 183 (2017) (61) conducted a randomized controlled study (N = 192), in patients declining surgery for DCM of Cerebrolysin, a mixture of amino-acids and peptides given via intramuscular injection, demonstrating neurological benefit for the treatment arm.…”
Section: Introductionmentioning
confidence: 99%
“…Further, Allam et al (2017), 43 conducted a randomised controlled study ( N = 192), where patients declining surgery for DCM were given Cerebrolysin, a mixture of amino-acids and peptides given via intramuscular injection. Although, both arms improved on average without surgery (a methodological concern), this was more likely, and of greater magnitude, in the treatment arm as measured using the Japanese Orthopaedic Association score.…”
Section: Discussionmentioning
confidence: 99%
“…A randomised controlled trial reported that administering Cerebrolysin, a mixture of amino acids and biologically active peptides, to DCM patients who declined surgery, led to significant improvements in their myelopathy, including JOA scores and mean JOA recovery rate after 6 months. 43 Similarly, oral creatine supplementation was shown to enhance exercise capacity in patients with cervical spinal cord injury (SCI), significantly improving oxygen uptake, carbon dioxide production and tidal volume at peak effort, with associated significantly higher peak power output; although, there was no significant effect on respiratory exchange ratio, minute ventilation and time to fatigue. 44 The effect of malnutrition on adverse events: surgical outcomes and complications.…”
Section: Malnutrition and Electrolyte Imbalancementioning
confidence: 99%
“…For this case, 30mg methylprednisolone per Kg of body weight was given intravenously within 15 minutes once neurological deterioration was found, and the medicine was used as reported in literatures [31]. Besides, dehydrate agents, neurotrophic and neuroprotective agents can be considered to protect and facilitate rehabilitation of spinal cord function, but there are short of consistent clinical evidence [22,[32][33]. Although often overlooked, compensation collateral circulation, including the system of epidural arcades in the immediate setting, and paraspinal collaterals in the long run, may play a role in functional recovery of spinal cord [34].…”
Section: Literature Reviewmentioning
confidence: 99%